The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

Former ET co-host John Tesh revealed he that he far exceeded the wildest expectations of doctors who diagnosed him with cancer more than a decade ago - but he still lives with the disease.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

John Tesh shared an update on his 10-year cancer journey in a new interview, saying he's 'still fighting it.' In 2015, the former 'Entertainment Tonight' co-host revealed that he had been diagnosed ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...

The U.S. Food and Drug Administration on Friday approved a new ​formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ‌scanning access through increased production ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Pub bells will ring out early this evening at 6pm – and each night over the next six days – as part of a new campaign by ...

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...

Despite a trend toward more patient-centered research, quality-of-life end points remain substantially underreported in phase ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

During last night's game presented by Emory Healthcare, the Atlanta Hawks Foundation, together with the Ressler Gertz Family Foundation, announced a $150,000 donation to the Prostate Cancer Foundation ...